Keywords
Cervical Dysplasia
Human Papillomavirus (HPV)
Thermocoagulation
How to Cite
Abstract
Cervical cancer (CC) remains one of the primary health concerns for women worldwide, with its prevalence in Poland posing a significant health challenge. Despite advancements in preventive treatments, this disease persists as one of the leading causes of morbidity and mortality among women. In Poland, its impact extends beyond individual health and patient quality of life, also affecting the healthcare system and the nation's economy.
References
Andrzej, N., Iwona, B., & Ma, M. (2008). Zachowania zdrowotne kobiet w zakresie zapobiegania, wczesnego wykrywania stanów przedrakowych i raka szyjki macicy. Ginekol Pol.
Baltzer, N., Sundström, K., Nygård, J. F., Dillner, J., & Komorowski, J. (2017). Risk stratification in cervical cancer screening by complete screening history: Applying bioinformatics to a general screening population. International Journal of Cancer, 141(1), 200–209. https://doi.org/10.1002/ijc.30725
Basta, T., Knapp, P., Blecharz, P., Bodnar, L., Gawron, I., Babczyk, D., Piróg, M., Kluz, T., Markowska, A., Horbaczewska, A., & Jach, R. (2019). Current management of cervical cancer in Poland—Analysis of the questionnaire trial for the years 2002-2014 in relation to ASCO 2016 recommendations. PLoS ONE, 14(1), e0209901. https://doi.org/10.1371/journal.pone.0209901
Bebyn, M. G., Śledzińska, P., Wojtysiak, J., Jóźwicki, W., Mierzwa, T., Dziedzic, J., Kowalewski, J., & Lewandowska, M. A. (2022). HPV RNA and DNA testing in Polish women screened for cervical cancer – A single oncological center study. European Journal of Obstetrics and Gynecology and Reproductive Biology, 268, 129–134. https://doi.org/10.1016/j.ejogrb.2021.11.427
Bedell, S. L., Goldstein, L. S., Goldstein, A. R., & Goldstein, A. T. (2020). Cervical Cancer Screening: Past, Present, and Future. Sexual Medicine Reviews, 8(1), 28–37. https://doi.org/10.1016/j.sxmr.2019.09.005
Bovo, A. C., Pedrão, P. G., Guimarães, Y. M., Godoy, L. R., Resende, J. C. P., Longatto-Filho, A., & Reis, R. dos. (2023). Combined Oral Contraceptive Use and the Risk of Cervical Cancer: Literature Review. RBGO Gynecology & Obstetrics, 45(12), e818–e824. https://doi.org/10.1055/s-0043-1776403
Bowden, S. J., Doulgeraki, T., Bouras, E., Markozannes, G., Athanasiou, A., Grout-Smith, H., Kechagias, K. S., Ellis, L. B., Zuber, V., Chadeau-Hyam, M., Flanagan, J. M., Tsilidis, K. K., Kalliala, I., & Kyrgiou, M. (2023). Risk factors for human papillomavirus infection, cervical intraepithelial neoplasia and cervical cancer: An umbrella review and follow-up Mendelian randomisation studies. BMC Medicine, 21, 274. https://doi.org/10.1186/s12916-023-02965-w
Bravi, F., Parazzini, F., Cipriani, S., Chiaffarino, F., Ricci, E., Chiantera, V., Viganò, P., & La Vecchia, C. (2014). Tobacco smoking and risk of endometriosis: A systematic review and meta-analysis. BMJ Open, 4(12), e006325. https://doi.org/10.1136/bmjopen-2014-006325
Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R. L., Soerjomataram, I., & Jemal, A. (2024). Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 74(3), 229–263. https://doi.org/10.3322/caac.21834
Ma̧dry, E., Gibas-Dorna, M., Adamczak-Ratajczak, A., & Ma̧dry, R. (2009). HPV - Multiple face virus. Family Medicine and Primary Care Review, 11, 702–704.
Magiera, K., Rybak, J., Magiera, B., Grabarczyk, A., & Grabowska-Szczurek, M. (2024). Rak szyjki macicy – czynniki ryzyka i nowe możliwości profilaktyki w Polsce. Medycyna Środowiskowa, 26(3–4), 109–113. https://doi.org/10.26444/ms/178419
Mak, R., Van Renterghem, L., & Cuvelier, C. (2004). Cervical smears and human papillomavirus typing in sex workers. Sexually Transmitted Infections, 80(2), 118–120. https://doi.org/10.1136/sti.2002.003749
Medard M, L., & Ostrowska, L. (2007). [Combined oral contraception and the risk of reproductive organs cancer in women]. Ginekologia Polska, 78(8), 637–641.
Nowakowski, A., Jackowska, T., Oszukowski, P. J., Radowicki, S., Wysocki, J., & Zatoński, W. (2013). Profilaktyka raka szyjki macicy – problem interdyscyplinarny. Czy i jak możemy poprawić sytuację w Polsce? Pediatria Polska, 88(4), 340–346. https://doi.org/10.1016/j.pepo.2013.05.005
Nowicki, A., Farbicka, P., & Anczura, K. (2017). Wiedza uczennic technikum i absolwentek studiów wyższych z zakresu profilaktyki i leczenia raka szyjki macicy. Pielęgniarstwo Polskie, 64(2), 246–253. https://doi.org/10.20883/pielpol.2017.32
Olejnik Anita. (b.d.). HPV jako czynnik etiologiczny raka szyjki macicy.
Pacewicz, M., Krajewska-Kułak, E., & Krajewska-Ferishah, K. (2012, październik 1). Profilaktyka raka szyjki macicy—Poziom wiedzy kobiet i mężczyzn. | Palliative Medicine / Medycyna Paliatywna | EBSCOhost. https://openurl.ebsco.com/contentitem/gcd:85489954?sid=ebsco:plink:crawler&id=ebsco:gcd:85489954
Pruski, D., Millert-Kalińska, S., Łagiedo, M., Sikora, J., Jach, R., & Przybylski, M. (2023). Effect of HPV Vaccination on Virus Disappearance in Cervical Samples of a Cohort of HPV-Positive Polish Patients. Journal of Clinical Medicine, 12(24), 7592. https://doi.org/10.3390/jcm12247592
Raporty | Krajowy Rejestr Nowotworów. (b.d.). Pobrano 5 czerwiec 2024, z http://onkologia.org.pl/pl/raporty
Stefanek, A., & Durka, P. (2014). POZIOM ŚWIADOMOŚCI KOBIET NA TEMAT PROFILAKTYKI RAKA SZYJKI MACICY.
Su, B., Qin, W., Xue, F., Wei, X., Guan, Q., Jiang, W., Wang, S., Xu, M., & Yu, S. (2018). The relation of passive smoking with cervical cancer. Medicine, 97(46), e13061. https://doi.org/10.1097/MD.0000000000013061
Szczepionka przeciw HPV. (b.d.). Szczepienia.Info. Pobrano 5 czerwiec 2024, z https://szczepienia.pzh.gov.pl/szczepionki/hpv/
Trojańczyk, M. (2012). HPV – szczepić czy nie szczepić?
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Copyright (c) 2024 Letters in Oncology Science